| Oral delivery of RNAi for cancer therapy H Afrin, R Geetha Bai, R Kumar, SS Ahmad, SK Agarwal, M Nurunnabi Cancer and Metastasis Reviews 42 (3), 699-724, 2023 | 27 | 2023 |
| Ionic liquid-mediated delivery of a BCL-2 inhibitor for topical treatment of skin melanoma MN Huda, IG Deaguero, EA Borrego, R Kumar, T Islam, H Afrin, ... Journal of Controlled Release 349, 783-795, 2022 | 20 | 2022 |
| Investigation of coagulation process of wet-spun sodium alginate polymannuronate fibers with varied functionality using organic coagulants and cross-linkers TH Aneem, SY Wong, H Afrin, M Nurunnabi, X Li, MT Arafat Materials Today Chemistry 22, 100580, 2021 | 15 | 2021 |
| Theoretical and experimental insights into the possible interfacial interactions between β-Glucan and fat molecules in aqueous media T Islam, MN Huda, MA Ahsan, H Afrin, C Joseph J Salazar, M Nurunnabi The Journal of Physical Chemistry B 125 (50), 13730-13743, 2021 | 11 | 2021 |
| Detection of anticancer drug-induced cardiotoxicity using VCAM1-targeted nanoprobes H Afrin, MN Huda, T Islam, BP Oropeza, E Alvidrez, MI Abir, T Boland, ... ACS applied materials & interfaces 14 (33), 37566-37576, 2022 | 10 | 2022 |
| β-Glucan-Mediated Oral Codelivery of 5FU and Bcl2 siRNA Attenuates Stomach Cancer H Afrin, SV Esquivel, R Kumar, MI Zahid, B Oporeza, MF Rahman, ... ACS applied materials & interfaces 15 (27), 32188-32200, 2023 | 8 | 2023 |
| Understanding the solubility and electrospinnability of gelatin using Teas approach in single/binary organic solvent systems MU Jahangir, SY Wong, H Afrin, M Nurunnabi, X Li, MT Arafat Bulletin of Materials Science 46 (1), 4, 2022 | 4 | 2022 |
| Detection of leptin using electrocatalyst mediated impedimetric sensing T Islam, MA Ahsan, M Hassan, H Afrin, J Pena-Zacarias, A Aldalbahi, ... ACS Biomaterials Science & Engineering 9 (5), 2170-2180, 2022 | 4 | 2022 |
| Methods of screening, monitoring and management of cardiac toxicity induced by chemotherapeutics H Afrin, CJ Salazar, M Kazi, SR Ahamad, M Alharbi, M Nurunnabi Chinese Chemical Letters 33 (6), 2773-2782, 2022 | 4 | 2022 |
| Mucoadhesive Carrier-Mediated Oral Co-delivery of Bcl2 Inhibitors Improves Gastric Cancer Treatment R Kumar, H Afrin, HN Bhatt, E Beaven, A Gangavarap, SV Esquivel, ... ACS Applied Materials & Interfaces 16 (1), 305-317, 2023 | 2 | 2023 |
| Oral delivery compositions for obesity management M Nurunnabi, H Afrin, MN Huda, CJJ Salazar US Patent App. 17/871,953, 2023 | 1 | 2023 |
| ORAL CODELIVERY OF 5-FLUOREURACIL AND Bcl2 siRNA TREATING STOMACH CANCER M Nurunnabi, H Afrin, R Kumar US Patent App. 18/742,639, 2024 | | 2024 |
| ORAL CODELIVERY OF NAVITOCLAX AND Bcl2 siRNA TREATING GASTIC CANCER M Nurunnabi, H Afrin, R Kumar US Patent App. 18/742,746, 2024 | | 2024 |
| Bcl2 Mediated Targeted Drug Delivery for the Treatment of Kidney Fibrosis and Stomach Cancer H Afrin The University of Texas at El Paso, 2024 | | 2024 |
| Targeted Therapy of Kidney Fibrosis M Nurunnabi, H Afrin US Patent App. 18/057,567, 2023 | | 2023 |
| Noninvasive Detection of Cardiotoxicity Induced by Chemotherapeutic H Afrin, M Nurulhuda, T Islam, M Nurunnabi Circulation 144 (Suppl_1), A14302-A14302, 2021 | | 2021 |
Md NurunnabiUniversity of MississippiAdresse e-mail validée de olemiss.edu